ask="1.1100"
ask_size="2200"
average_daily_volume="337648"
bid="0.6000"
bid_size="200"
book_value="0.1250"
change="+0.0399"
change_from_200_day_moving_average="-0.3069"
change_from_50_day_moving_average="-0.0062"
change_from_52_week_high="-2.0601"
change_From_52_week_low="0.4999"
change_in_percent="+4.2000%"
close="0.9899"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.8300"
ebitda="-21.56M"
eps_estimate_current_year="-0.8100"
eps_estimate_next_quarter="-0.1800"
eps_estimate_next_year="-0.8700"
ex_dividend_date="N/A"
float_shares="19095000"
high="0.9900"
high_52_weeks="3.0500"
last_trade_date="1/25/2017"
last_trade_price="0.9899"
last_trade_size="166"
last_trade_time="3:58pm"
low="0.9500"
low_52_weeks="0.4900"
market_capitalization="29.10M"
moving_average_200_day="1.2968"
moving_average_50_day="0.9961"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="1.1200"
open="0.9800"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-23.6654%"
percent_change_from_50_day_moving_average="-0.6185%"
percent_change_from_52_week_high="-67.5443%"
percent_change_from_52_week_low="+102.0204%"
previous_close="0.9500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.6000"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29396000"
short_ratio="4.2200"
stock_exchange="NCM"
symbol="GALT"
volume="106737"
weeks_range_52="0.4900 - 3.0500"
